Entropia Signs Isis Pharmaceuticals as First Life Sciences Peer-to-Peer Computing Customer | GenomeWeb

Entropia clinched a crucial client win recently as Isis Pharmaceuticals agreed to use the company’s DCGrid product line to distribute its computational tasks among its network of PCs and laptops.

While unable to disclose any details on the number of PCs hooked into the network, Martin Stuart, Entropia’s vice president of life sciences, said “the scale of the network we’re enabling within Isis will significantly surpass their existing Linux cluster capability.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.